These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 21441115)
1. The courage of one's convictions: the due diligence of Frances Oldham Kelsey at the FDA. Scheindlin S Mol Interv; 2011 Feb; 11(1):3-9. PubMed ID: 21441115 [No Abstract] [Full Text] [Related]
2. Frances Kelsey honored for FDA legacy: award notes her work on thalidomide, clinical trials. Kuehn BM JAMA; 2010 Nov; 304(19):2109-10, 2112. PubMed ID: 21081717 [No Abstract] [Full Text] [Related]
3. Frances Oldham Kelsey. FDA medical reviewer leaves her mark on history. Bren L FDA Consum; 2001; 35(2):24-9. PubMed ID: 11444245 [No Abstract] [Full Text] [Related]
5. Show drugs work before selling them. Sipp D; McCabe C; Rasko JE Nature; 2017 Mar; 543(7644):174-175. PubMed ID: 28277530 [No Abstract] [Full Text] [Related]
6. 50 Years Ago in The Journal of Pediatrics: Editorial Comment: Therapeutic Orphans. Ross LF J Pediatr; 2018 Jan; 192():59. PubMed ID: 29246359 [No Abstract] [Full Text] [Related]
7. A tale of two experts: thalidomide and political engagement in the United States and West Germany. Daemmrich A Soc Hist Med; 2002 Apr; 15(1):137-58. PubMed ID: 12625358 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic disasters that hastened safety testing of new drugs. Paine MF Clin Pharmacol Ther; 2017 Apr; 101(4):430-434. PubMed ID: 28318023 [TBL] [Abstract][Full Text] [Related]
9. [On the history of the Contergan (thalidomide) catastrophe in the light of drug legislation]. Maio G Dtsch Med Wochenschr; 2001 Oct; 126(42):1183-6. PubMed ID: 11607860 [No Abstract] [Full Text] [Related]
10. Déjà Vu at the FDA. Sharfstein J Milbank Q; 2017 Jun; 95(2):245-248. PubMed ID: 28378412 [No Abstract] [Full Text] [Related]
11. Learning about the safety of drugs--a half-century of evolution. Avorn J N Engl J Med; 2011 Dec; 365(23):2151-3. PubMed ID: 22150034 [No Abstract] [Full Text] [Related]
12. Food and Drug Administration centennial: recognizing the guardians of our drug supply. Beary JF Arthritis Rheum; 2006 Oct; 54(10):3374. PubMed ID: 17009312 [No Abstract] [Full Text] [Related]
14. Drug development and FDA approval, 1938-2013. Darrow JJ; Kesselheim AS N Engl J Med; 2014 Jun; 370(26):e39. PubMed ID: 24963591 [No Abstract] [Full Text] [Related]
15. Sure cure: public policy on drug efficacy before 1962. Swann JP Publ Am Inst Hist Pharm; 1997; 16():223-61. PubMed ID: 11619897 [No Abstract] [Full Text] [Related]
16. 100 years of biologics regulation. FDA Consum; 2002; 36(4):8-10. PubMed ID: 12184315 [No Abstract] [Full Text] [Related]
17. Thalidomide and the Titanic: reconstructing the technology tragedies of the twentieth century. Annas GJ; Elias S Am J Public Health; 1999 Jan; 89(1):98-101. PubMed ID: 9987477 [TBL] [Abstract][Full Text] [Related]
18. Thalidomide: was the tragedy preventable? Dally A Lancet; 1998 Apr; 351(9110):1197-9. PubMed ID: 9643709 [No Abstract] [Full Text] [Related]
19. A brief history of calcitonin. Colman E; Hedin R; Swann J; Orloff D Lancet; 2002 Mar; 359(9309):885-6. PubMed ID: 11897305 [No Abstract] [Full Text] [Related]
20. The history and contemporary challenges of the US Food and Drug Administration. Borchers AT; Hagie F; Keen CL; Gershwin ME Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]